JC virus in CD34+ and CD19+ cells in patients with multiple sclerosis treated with natalizumab

导出原文传递

翻译打印收藏纠错

作者： Frohman,E.M. ^[1] ; Monaco,M.C. ^[2] ; Remington,G. ^[3] ; Ryschkewitsch,C. ^[4] ; Jensen,P.N. ; Johnson,K. ; Perkins,M. ; Liebner,J. ; Greenberg,B. ; Monson,N. ; Frohman,T.C. ; Douek,D. ; Major,E.O.

作者单位： Department of Neurology, University of Texas, South Western Medical Center, 5323 Harry Hines Blvd ^[1] Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious ^[2] Laboratory of Molecular Medicine and Neuroscience, National Institutes of Health (NIH), Bethesda ^[3] Bioinformatics Section, National Institute of Neurological and Communicative Diseases and Stroke ^[4]

发布时间 2015-03-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

JAMA neurology

2014年71卷5期

596-602页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

JC virus in CD34+ and CD19+ cells in patients with multiple sclerosis treated with natalizumab

JAMA neurology

相似文献

JAMA neurology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

JC virus in CD34+ and CD19+ cells in patients with multiple sclerosis treated with natalizumab

JAMA neurology

相似文献

JAMA neurology

相关期刊

检索历史清除